In this cross-sectional study of adults hospitalized with respiratory syncytial virus (RSV) before the 2023 introduction of RSV vaccines, RSV was associated with substantial burden of hospitalizations ...
In addition, annual estimates of RSV-associated ICU admissions ranged from 24,400 to 34,900 for the 2016-2017 and 2017-2018 ...
The mortality risk within 90 days of hospitalization is similar and higher among older adults hospitalized with respiratory syncytial virus (RSV) vs influenza A and those hospitalized with RSV vs ...
Regarding hospitalizations among immunocompetent older adults, vaccine effectiveness was 83% for the GSK vaccine and 73% for ...
(Reuters) -Moderna said on Friday Canada's health regulator has approved its vaccine for respiratory syncytial virus in ...
Moderna reported a surprising third-quarter profit on Thursday, driven by cost reductions and stronger-than-expected sales of ...
Public health experts are warning that the rising rates of RSV in the Southern U.S. could be a sign we need to prepare here in Southern California At one hospital in Texas, doctors are sounding the ...